Symposium

Barrow Neurological Institute at Phoenix Children's 2024 Innovation Report

The 2024 Innovation Report highlights some of the transformative work accomplished over the past year. From groundbreaking clinical programs to cutting-edge research and novel therapeutic approaches, our multidisciplinary teams have worked ...

News

Cerebral Vasculopathy in Neurofibromatosis Type 1: An Under-Recognized Problem?

Neurofibromatosis type 1 (NF1) is a common genetic disorder caused by mutations in the NF1 gene, which encodes neurofibromin, a GTPase-activating protein (GAP)-related domain that negatively regulates the Ras/mitogen-activated protein ...

News

Advancing the Care of Children with Cerebrovascular Disease

Pediatric cerebrovascular disease is a significant cause of global morbidity and mortality among children.

News

The Future of Pediatric Epilepsy Surgery Through a Genetic Lens

Epilepsy in children continues to be a large-scale medical issue in children, affecting approximately 4 in 1,000 children each year. Epilepsy is defined as having two unprovoked, nonfebrile seizures.

News

Hypoglossal Nerve Stimulation: A Novel Tool for Treating Obstructive Sleep Apnea in Children

Hypoglossal nerve stimulation is an advanced and emerging therapeutic approach designed to manage obstructive sleep apnea (OSA).

News

Phoenix Children’s Names New Chief of Neurosurgery

Phoenix Children’s, one of the nation’s fastest-growing pediatric health systems, today announced the hire of accomplished surgeon-scientist Jason Scott Hauptman, MD, PhD, as division chief of neurosurgery, part of Barrow Neurological ...